Home page > Publications > MGHI papers
MGHI papers
Metronomic Scheduling of Anticancer Treatment The Next Generation Of Multitarget Therapy?
Future Oncology. 2011;7(3):385-394. © 2011 Future Medicine Ltd.
Metronomics : India showing the way !
As part of the metronomic special that has been released in the Indian Journal of Cancer, MGHI members Nicolas ANDRE and Eddy PASQUIER have written a short editorial commissioned by the editor of the journal where we try to pust in perspective the papers that have been published in thsi special issue. You can have acces to the full text by clicking (...)
Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch ?
In a recent opinion paper entitled : Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch published in Frontiers in Oncology Prabhat S. Malik Vinod Raina and Nicolas André from the Metronomics Global Health Initiative, France , the Medical Oncology, All India Institute of Medical Sciences, the Medical Oncology, Fortis Memorial (...)
Metronomics chemotherapy: time for computational decision support.
A new article on metronomic chemotherapy has just been accepted for publication in Cancer Chemotherapy Pharmacology. The paper is entitled Metronomics chemotherapy: time for computational decision support and has been written by mathematicians, pharmacists, researchers and clinicians. It hilights the fact that computational pharmacology could help (...)
Metronomics during palliative care in paediatric oncology? For sure! But handle me with care
Following the article entitled Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential by Porkholm published in Acta Paediatr 2016 the editors have asked us to write an acompgnying short editorial piece. Metronomic chemotherapy (MC) is low-dose chemotherapy that is (...)
Metronomics maintenance for HGNET-BCOR tumors of the cerebellum
In a recent article entitled : HGNET-BCOR Tumors of the Cerebellum Clinicopathologic and Molecular Characterization of 3 Cases by Romain Appay and al. in press in the American Journal of Surgical Pathology, the authors from the departments of Pathology and Neuropathology-Radiotherapy-Hematology & Pediatric Oncology-Pediatric Neurosurgery, Timone (...)
Metronomics — fulfilling unmet needs beyond level A evidence
We have just published in Nature Reviews Clinical Oncology a short piece about metronomic chemotherapy and drug repositioning entitled "Metronomics — fulfilling unmet needs beyond level A evidence" The 3 authors are MGHI members : Nicolas André, Shripad Banavali and Eddy Pasquier from the Inserm UMR_S 911, Centre de Recherche en Oncologie biologique et (...)
Metronomics: intrinsic anakoinosis modulator ?
As part of a "research topic" on anakoinosis, opened for submission in Fontiers in Pharmacology, Nicolas André, Manon Carré and Eddy Pasquier from the Department of Pediatric Hematology-Oncology, Assistance Publique Hôpitaux de Marseille, France, the Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Aix Marseille (...)
Metronomics: towards personalized chemotherapy?
Our recent comissioned review written by Nicolas ANDRE, Manon CARRE and Eddy PASQUIER from the Service d’Hématologie & Oncologie Pédiatrique, AP-HM, the INSERM UMR 911, Centre de Recherche en Oncologie Biologique et Oncopharmacologie, Aix-Marseille University France and the Children’s Cancer Institute Australia, Lowy Cancer Research Centre, (...)
Modeling the Impact of Anticancer Agents on Metastatic Spreading
A collaboration between MGHI, the CMI-LATP and the Laboratoire de Toxicocinétique et Pharmacocinétique both from Marseille has lead to a publication entitled : Modeling the Impact of Anticancer Agents on Metastatic Spreading S. Benzekry, N. André, A. Benabdallah, J. Ciccolini, C. Faivre, F. Hubert and D. Barbolosi published in Mathematical Modelling of (...)
